Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis

Background: Sodium–glucose co-transporter 2 (SGLT2) inhibitors are an emerging class of glucose-lowering drugs that have become increasingly relevant for the treatment and prevention of heart failure (HF). Therefore, we aimed to investigate various SGLT2 inhibitors in patients with established HF at...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Cardiovasc Med
Egile Nagusiak: Gager, Gloria M., Gelbenegger, Georg, Jilma, Bernd, von Lewinski, Dirk, Sourij, Harald, Eyileten, Ceren, Filipiak, Krzysztof, Postula, Marek, Siller-Matula, Jolanta M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2021
Gaiak:
Cardiovascular Medicine
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8316592/
https://ncbi.nlm.nih.gov/pubmed/34336954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2021.691907
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak